iMediSync

About iMediSync

An AI digital mental health platform company that has developed a cloud-based AI-powered brainwave and heartbeat analysis software for early detection and management of various neurological and psychiatric disorders, including dementia, depression, ADHD, and addiction.

The company's main product, iSyncWave, is a quick and efficient tool for recording and phenotyping brainwaves, enabling the development of electrophysiological biomarkers for mental health conditions. This technology is designed to be used by healthcare professionals to aid in the diagnosis and monitoring of patients.

iMediSync operates in the healthcare technology sector, specifically focusing on mental health diagnostics. Its clients are likely to be hospitals, clinics, and research institutions that require advanced tools for assessing brain health. The business model appears to be centered around providing this software as a service (SaaS) to these healthcare providers.

By leveraging artificial intelligence, iMediSync aims to provide a more objective and data-driven approach to mental healthcare, moving beyond traditional subjective assessments. The company is based in Seoul, South Korea, and has attracted investment from various venture capital firms.